LANXESS Solutions US Inc. 4
4 · LANXESS Solutions US Inc. · Filed Apr 24, 2017
Insider Transaction Report
Form 4
BENJAMIN JEFFREY D
Director
Transactions
- Disposition to Issuer
Common Stock
2017-04-21$33.50/sh−41,158$1,378,793→ 0 total - Disposition to Issuer
Common Stock
2017-04-21$33.50/sh−50,000$1,675,000→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2017-04-21$33.50/sh−5,000$167,500→ 0 total(indirect: By Trust)
Footnotes (3)
- [F1]On September 25, 2016, Chemtura Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Lanxess Deutschland GmbH ("Lanxess") and LANXESS Solutions US Inc. (f/k/a LANXESS Additives Inc.) ("Merger Subsidiary"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Company, whereupon the existence of Merger Subsidiary will cease and the Company will become the surviving corporation and a wholly-owned subsidiary of Lanxess. The Merger became effective on April 21, 2017 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Company's common stock, par value $0.01, outstanding immediately prior to the Effective Time was converted into the right to receive $33.50 in cash, without interest.
- [F2]These shares are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]These shares are held in a trust for the benefit of the reporting person's spouse and children. Neither the reporting person nor his spouse is the trustee. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.